-
1 Comment
Recro Pharma, Inc is currently in a long term downtrend where the price is trading 29.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Recro Pharma, Inc's total revenue sank by 43.8% to $10M since the same quarter in the previous year.
Its net income has dropped by 22.7% to $-12M since the same quarter in the previous year.
Finally, its free cash flow grew by 118.2% to $687K since the same quarter in the previous year.
Based on the above factors, Recro Pharma, Inc gets an overall score of 2/5.
Sector | Healthcare |
---|---|
Industry | Pharmaceuticals |
Exchange | NASDAQ |
CurrencyCode | USD |
ISIN | US75629F1093 |
Market Cap | 123M |
---|---|
PE Ratio | None |
Target Price | 5 |
Dividend Yield | 0.0% |
Beta | 1.12 |
Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for REPH using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025